Latest BD Stories

FRANKLIN LAKES, N.J., Dec. 26, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has completed its acquisition of Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. The financial terms were not disclosed. The acquisition broadens BD's healthcare worker safety offering to include passive safety...

FRANKLIN LAKES, N.J., Dec. 21, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in January 2013: Goldman Sachs Healthcare CEOs Unscripted: A View From The TopJanuary 3, 20131:00 p.m. ET 31(st) Annual J. P. Morgan Healthcare ConferenceJanuary 9, 201311:30 a.m. ET Live webcasts of BD's presentations can be accessed on the BD corporate...

FRANKLIN LAKES, N.J., Nov. 21, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will present at the 24(th) Annual Piper Jaffray Healthcare Conference Wednesday, November 28, 2012, at 9:30 a.m. EST. A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors, and will be available for replay through Wednesday, December 5, 2012. About BD BD is a leading...

LONDON, November 15, 2012 /PRNewswire/ -- British architects have potential to transform hotel sector 12 architects have been shortlisted in a competition to design the budget hotel room of the future. (Logo: http://photos.prnewswire.com/prnh/20121115/574148 ) Read the full story [http://www.bdonline.co.uk/story.aspx?storyCode=5045942 ] The competition, organised by the UK's leading architecture newspaper BD and Bdonline.co.uk,...

FRANKLIN LAKES, N.J., Nov. 6, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of William A. Kozy as Chief Operating Officer, effective today. Mr. Kozy adds this title to his current title of Executive Vice President. He will continue to report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President. "Bill's new title reflects his leadership role and the additional...

FRANKLIN LAKES, N.J., Nov. 1, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the completion of the sale of its BD Biosciences - Discovery Labware unit, excluding its Advanced Bioprocessing platform, to Corning Incorporated (NYSE:GLW), the world leader in specialty glass and ceramics. On April 9, 2012, BD announced that it had signed an agreement to sell these assets to Corning. The Company expects to...

FRANKLIN LAKES, N.J., Oct. 29, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it has received the WindMade(TM) label, a global consumer label for companies that use wind energy and other renewable energy sources. BD received the WindMade(TM) label for the Company's global operations, and certifies that 35% of BD's total electricity consumption is from wind power. The label, which is backed by the...

NASA Science [ Watch The Video ] An international team of astronomers has caught a star in the act of devouring one of its planets. BD+48 740, a red giant they observed using the 9.2-meter Hobby-Eberly Telescope at the McDonald Observatory in Texas, appears to have the fumes of a scorched planet in its atmosphere. This is consistent with a rocky world, recently destroyed. Could the same thing happen to Earth? Yes indeed, says Alex Wolszczan, a member of the research team from Penn...

BALTIMORE and CAMBRIDGE, England, Oct. 15, 2012 /PRNewswire/ -- BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Lab21, a global leader in personalized healthcare diagnostics, announced today that they will collaborate to develop oncology assays for the BD MAX(TM) fully automated, bench-top molecular system. Under the terms of the collaboration, Lab21 will develop polymerase chain reaction-based assays on the BD...

FRANKLIN LAKES, N.J., Oct. 11, 2012 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that the BD Vystra(TM) Disposable Pen will be showcased at the 2012 Parenteral Drug Association Meeting in Las Vegas. This new self-injection pen has been designed for use with a wide range of therapies that require frequent, low-volume injections or variable dosing. BD Vystra(TM) Disposable Pen has been optimized for ease of use, comfort and...